Searched for
HIV THERAPY
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Promising HIV cure could be achieved through children: Decade long tests revealGlobal HIV research indicates a potential cure for children through early antiretroviral therapy (ART). A small group of HIV-infected infan...
- World AIDS Day 2024: AIDS and HIV are often confused as the same disease. Debunking the popular mythWorld AIDS Day 2024: Thanks to advancements in treatment, HIV is no longer a death sentence. By adhering to antiretroviral therapy, people ...
- How drugs were used to spread HIV among 800+ students in TripuraTripura is grappling with a severe HIV outbreak among its student population, exacerbated by injectable drug use. According to Tripura Stat...
- HIV treatment: Can cancer medicine cure HIV patients? Here's what researchers, doctors have foundScientists at a Melbourne research institute in Australia have found that a medicine used to treat blood cancer can kill HIV cells. Know in...
- Health Ministry implements HIV, AIDS ActThe act seeks to prevent and control the spread of HIV and AIDS and and creates mechanisms for redressing the complaints of persons infecte...
- Young HIV patients can now live a normal life with the help of new drugsA 20-year-old who began therapy in 2008 can now live up to 78 years, says a new study.
- HIV drugs may take a toll on brain, says studyLife-changing medicines for HIV patients may lead to forgetfulness, confusion and behavioural changes.
- Biomarkers of cognitive impairment found in HIV patients: StudyNew York, Sep 25 (IANS) Using reliable biomarkers, researchers have found a unique epigenetic footprint which offers them insight into how ...
- ART can help HIV positive person live normal lifespan: ExpertAccording to IAPAC guidelines 2015, an estimated 50 per cent of people living with HIV globally are unaware of their status.
- Cipla ready to launch low dose HIV drug 'Efavirenz'Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.
- New breakthrough may lead to HIV relapse cureScientists are now better able to predict how quickly the HIV virus will return after individuals stop treatment.
- Early HIV treatment may save patients diagnosed with tuberculosisStarting anti-HIV treatment within two weeks of the diagnosis of tuberculosis improved survival among patients with both infections, a new ...
- On World AIDS Day, Larsen & Toubro opens new anti-retroviral therapy centreThe centre, owned by the Municipal Corporation of Greater Mumbai (MCGM), has been built by L&T, which will also operate it.
- New therapy may offer HIV cureScientists used radioimmunotherapy to destroy remaining human immunodeficiency virus -infected cells in the blood samples of patients treat...
- Research suggests HIV 'invisibility cloak' may lead to new AIDS treatmentThe innate immune system is the body's first line of defence against infection and incorporates an alarm system present in all cells of the...
- US bio-pharma firm Gilead Sciences in pact with four Indian cosUS-based bio-pharmaceutical company Gilead Sciences on Tuesday entered into new licensing pacts with four Indian firms.
- Suven Life Sciences to develop therapy for HIVDrug maker Suven Life Sciences on Thursday entered into a collaboration with US-based Minnesota University to develop new therapies to trea...
- Matrix signs licensing deal with US coPharmacuetical company, Matrix Laboratories Ltd on Friday said it signed a licensing agreement with Gilead for manufacture and sale of a ge...
Load More
